Opendata, web and dolomites

T-CONTROL

Novel catheter to reduce Urinary Tract Infections (UTIs)

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 T-CONTROL project word cloud

Explore the words cloud of the T-CONTROL project. It provides you a very rough idea of what is the project "T-CONTROL" about.

events    reduce    membrane    ipr    patent    innovative    14b    29    letters    investment    mentioned    16    sl    savings    urinary    nursing    special    interventions    solutions    injury    indwelling    professionals    14    substentially    safety    sme    quality    catheter    introduction    acute    waste    uc    competition    causing    route    diapers    linked    emergency    stakeholders    decline    urine    deaths    commercializing    financial    sheets    care    spinal    gloves    ratification       made    mainly    incontinence    prostate    hydrophobic    stage    channels    difference    revenues    bags    eur    approval    prescribers    visits    conclude    life    thanks    workers    investments    retention    treatment    direct    plan    hospitals    material    custom    previously    rethink    muscle    hypertrophy    develops    cord    sharp    decreasing    continence    days    pave    business    frequent    alone    representing    health    bn    unmet    market    raised    assessing    frequently    catheters    additional    hospitalization    million    foreseeing    medical    patients    guarantee    customers    feasibility    weak    infection    risk   

Project "T-CONTROL" data sheet

The following table provides information about the project.

Coordinator
RETHINK MEDICAL SL 

Organization address
address: C/ PRACTICANTE IGNACIO RODRIGUEZ S/N - EDIFICIO PO II DEL CAMPUS UNIVERSITARIO DE TAFIRA
city: LAS PALMAS DE GRAN CANARIA
postcode: 35017
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Spain [ES]
 Project website http://www.rethinkmedical.es
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2018
 Duration (year-month-day) from 2018-08-01   to  2018-11-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    RETHINK MEDICAL SL ES (LAS PALMAS DE GRAN CANARIA) coordinator 50˙000.00

Map

 Project objective

T-Control is an innovative indwelling urinary catheter. Urinary Catheters (UC) are one of the most frequently used medical devices on the market. They are used during medical interventions and treatment, as well as incontinence or urine retention in case of spinal cord injury, prostate hypertrophy, weak muscle, and many other conditions.

There are several unmet needs related to currently used catheters. They cause a sharp decline of quality of life of the patients, are linked to frequent emergency visits and increase substentially the risk of infection both for patients and health care professionals. There are about 1,3 million cases in EU, causing 1,8 bn EUR direct cost and more than 14,000 deaths.

T-Control is addressing all the previously mentioned problems thanks to its novel design and a special hydrophobic membrane material, with patent approval both in EU and US, developed after 4 years of R&D.

T-Control will reduce additional days of hospitalization (leading to €1.14B savings in EU alone), but also guarantee the safety of health workers and decreasing continence related waste (sheets, gloves, diapers, catheters, bags…) representing around 29% of medical waste in non-acute hospitals.

Rethink Medical SL develops new medical solutions, mainly linked to nursing. It raised the interest of 16 stakeholders on the market (Letters of Support).

The feasibility study (SME Phase 1) shall address a financial plan, foreseeing all the costs and investments associated with commercializing our custom-made UC and the expected revenues. The study will also aim at assessing other important aspects such as IPR management, determine the best investment route for the growth stage, and conclude the best channels to reach customers and how we can best explain our difference from competition (prescribers, events, hospitals…). All these activities will lead to the ratification of a detailed business plan that will pave the way towards an effective market introduction.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "T-CONTROL" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "T-CONTROL" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

COPI (2020)

Carbon Offset Plug-in

Read More  

DeltaQon (2019)

IOT and cloud computing for online medical analysis service platform

Read More  

Dyme (2019)

Dyme gives its users complete control over their financial situation. The Dyme application provides insight into users’ spending and subscriptions, and lets users cancel, negotiate, or switch any cont

Read More